Greater Midwest Financial Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$793K Sell
3,151
-126
-4% -$27.1K 0.4% 33
2026
Q1
$713K Buy
3,277
+12
+0.4% +$2.66K 0.38% 38
2025
Q4
$746K Buy
3,265
+23
+0.7% +$5.24K 0.42% 37
2025
Q3
$751K Buy
3,242
+884
+37% +$180K 0.48% 35
2025
Q2
$438K Sell
2,358
-77
-3% -$14.3K 0.33% 37
2025
Q1
$510K Buy
2,435
+5
+0.2% +$972 0.36% 36
2024
Q4
$432K Sell
2,430
-370
-13% -$68K 0.27% 40
2024
Q3
$553K Buy
2,800
+5
+0.2% +$933 0.32% 42
2024
Q2
$539K Buy
2,795
+17
+0.6% +$2.82K 0.34% 40
2024
Q1
$506K Buy
2,778
+9
+0.3% +$1.55K 0.32% 39
2023
Q4
$429K Buy
+2,769
New +$404K 0.29% 38

Other funds holding ABBV

Greater Midwest Financial Group's ABBV Position: Q2 2026 in Review

Greater Midwest Financial Group reduced its AbbVie (ABBV) stake by 3.8% in Q2 2026, selling an estimated $27.1K and leaving 3,151 shares worth $793K. The position accounts for 0.4% of the portfolio, ranked #33.

Greater Midwest Financial Group first reported a position in ABBV in Q4 2023 and has held it in 11 quarters since. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Greater Midwest Financial Group held 3,151 shares of AbbVie worth $793K as of Q2 2026.
  • Greater Midwest Financial Group sold 126 AbbVie shares in Q2 2026, an estimated $27.1K.
  • AbbVie made up 0.4% of Greater Midwest Financial Group's portfolio in Q2 2026, its #33 holding.
  • Greater Midwest Financial Group first reported a position in AbbVie in Q4 2023 and has held it in 11 quarters since.
  • 1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Greater Midwest Financial Group's 13F filing for Q2 2026, filed 15 Jul 2026.